Naruse M - Search Results

1

Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.

Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M. Umakoshi H, et al. Among authors: naruse m. Clin Endocrinol (Oxf). 2015 Oct;83(4):462-7. doi: 10.1111/cen.12761. Epub 2015 Mar 16. Clin Endocrinol (Oxf). 2015. PMID: 25727719

2

Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism.

Zeng ZP, Naruse M, Guan BJ, Naruse K, Sun ML, Zang MF, Demura H, Shi YF. Zeng ZP, et al. Among authors: naruse m, naruse k. J Clin Endocrinol Metab. 1992 Apr;74(4):874-8. doi: 10.1210/jcem.74.4.1548353. J Clin Endocrinol Metab. 1992. PMID: 1548353

3

Postural suppression of plasma atrial natriuretic polypeptide concentrations in man.

Sakurai H, Naruse M, Naruse K, Obana K, Higashida T, Kurimoto F, Demura H, Inagami T, Shizume K. Sakurai H, et al. Among authors: naruse m, naruse k. Clin Endocrinol (Oxf). 1987 Feb;26(2):173-8. doi: 10.1111/j.1365-2265.1987.tb00774.x. Clin Endocrinol (Oxf). 1987. PMID: 2959403

4

Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.

Naruse M, Naruse K, Yoshimoto T, Tanaka M, Tanabe A, Imaki T, Shibasaki T, Demura R, Demura H. Naruse M, et al. Among authors: naruse k. Hypertens Res. 1995 Jun;18 Suppl 1:S59-64. doi: 10.1291/hypres.18.supplementi_s59. Hypertens Res. 1995. PMID: 8529076 Free article. Clinical Trial.

5

C-type natriuretic peptide as a possible local modulator of aldosterone secretion in bovine adrenal zona glomerulosa.

Kawai M, Naruse M, Yoshimoto T, Naruse K, Shionoya K, Tanaka M, Morishita Y, Matsuda Y, Demura R, Demura H. Kawai M, et al. Among authors: naruse m, naruse k. Endocrinology. 1996 Jan;137(1):42-6. doi: 10.1210/endo.137.1.8536640. Endocrinology. 1996. PMID: 8536640

6

Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.

Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H. Tanabe A, et al. Among authors: naruse m, naruse k. Hypertens Res. 1997 Jun;20(2):85-90. doi: 10.1291/hypres.20.85. Hypertens Res. 1997. PMID: 9220271 Free article.

7

Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.

Yoshimoto T, Naruse M, Tanabe A, Naruse K, Seki T, Imaki T, Muraki T, Matsuda Y, Demura H. Yoshimoto T, et al. Among authors: naruse m, naruse k. Endocrinology. 1998 Jan;139(1):81-8. doi: 10.1210/endo.139.1.5644. Endocrinology. 1998. PMID: 9421401

8

Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.

Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K. Tanabe A, et al. Among authors: naruse m. J Clin Endocrinol Metab. 2003 Jun;88(6):2489-94. doi: 10.1210/jc.2002-021476. J Clin Endocrinol Metab. 2003. PMID: 12788844

9

[Aldosterone].

Tanabe A, Tsuiki M, Watanabe D, Takagi S, Takano K, Naruse M. Tanabe A, et al. Among authors: naruse m. Rinsho Byori. 2004 Aug;52(8):704-10. Rinsho Byori. 2004. PMID: 15478626 Review. Japanese.

10

[Blockade of renin-angiotensin system and aldosterone breakthrough].

Naruse M, Nagata D, Seta K, Tanabe A. Naruse M, et al. Nihon Rinsho. 2005 Mar;63 Suppl 3:201-5. Nihon Rinsho. 2005. PMID: 15813068 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters